Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
4.013
+0.103 (2.62%)
Nov 21, 2024, 4:00 PM EST - Market closed
Xenetic Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6 | 5 | 4 | 17 | 18 | 8 | |
| Market Cap Growth | -11.29% | 22.93% | -74.96% | -3.19% | 115.27% | -46.26% | |
| Enterprise Value | -1 | -4 | -10 | -2 | 11 | -4 | |
| Last Close Price | 3.99 | 3.45 | 2.85 | 12.90 | 20.40 | 14.40 | |
| PS Ratio | 2.44 | 2.09 | 2.53 | 14.88 | 40.83 | 485.61 | |
| PB Ratio | 0.87 | 0.54 | 0.32 | 0.94 | 1.46 | 0.48 | |
| P/TBV Ratio | 0.95 | 0.54 | 0.32 | 0.94 | 1.46 | 1.04 | |
| EV/Sales Ratio | - | - | - | - | 24.69 | - | |
| Debt / Equity Ratio | - | - | - | 0.00 | 0.01 | - | |
| Asset Turnover | 0.25 | 0.20 | 0.10 | 0.07 | 0.03 | 0.00 | |
| Quick Ratio | 6.78 | 11.10 | 12.20 | 12.84 | 12.30 | 7.33 | |
| Current Ratio | 6.96 | 11.84 | 12.72 | 13.18 | 13.20 | 7.84 | |
| Return on Equity (ROE) | -45.48% | -35.27% | -40.90% | -36.88% | -74.03% | -94.19% | |
| Return on Assets (ROA) | -27.25% | -22.29% | -24.32% | -21.77% | -16.90% | -29.54% | |
| Return on Capital (ROIC) | -30.40% | -24.08% | -26.19% | -23.40% | -19.90% | -39.18% | |
| Earnings Yield | -65.89% | -77.78% | -151.53% | -32.69% | -61.06% | -154.15% | |
| FCF Yield | -47.46% | -77.40% | -107.46% | -27.43% | -23.92% | -77.22% | |
| Buyback Yield / Dilution | -1.34% | -7.44% | -38.38% | -60.81% | -124.10% | -277.30% | |
| Total Shareholder Return | -1.34% | -7.44% | -38.38% | -60.81% | -124.10% | -277.30% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.